SCHEMBL7243154

SCHEMBL7243154

CNC(=O)c1cccc(NC(=O)Cc2ccc(OC)c(OC)c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.69
SMN1; SMN2 Q16637 6/20 0.69
HTT P42858 4/20 0.69
KMT2A Q03164 4/20 0.69
STAT3 P40763 2/20 0.66
KDM4E B2RXH2 1/20 0.65
EPHX2 P34913 1/20 0.60
NPSR1 Q6W5P4 4/20 0.58
ALDH1A1 P00352 3/20 0.58
MAPT P10636 3/20 0.58
TSHR P16473 3/20 0.58
MAPK1 P28482 3/20 0.58
HSD17B10 Q99714 3/20 0.58
MEN1 O00255 2/20 0.58
TP53 P04637 2/20 0.56
HPGD P15428 1/20 0.56
XBP1 P17861 1/20 0.56
HTR1E P28566 1/20 0.56
NTSR1 P30989 1/20 0.56
STAT1 P42224 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7244907 0.88 SMN1; SMN2 (0.66) LMNASMN1; SMN2HTTKMT2ASTAT3
SCHEMBL7242115 0.85 NLRP3 (0.69) LMNASMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL7238120 0.84 USP2 (0.67) SMN1; SMN2KMT2AALDH1A1MEN1TP53
SCHEMBL7239156 0.83 USP2 (0.57) SMN1; SMN2KMT2AALDH1A1MAPTMAPK1
SCHEMBL3653095 0.82 EPHX2 (0.77) LMNASMN1; SMN2HTTKMT2ASTAT3
SCHEMBL7239646 0.81 NLRP3 (0.67) SMN1; SMN2KMT2AKDM4EALDH1A1MAPT
SCHEMBL7236516 0.81 NLRP3 (0.59) SMN1; SMN2KMT2AKDM4EALDH1A1MAPT
SCHEMBL7246958 0.81 KMT2A (0.72) LMNASMN1; SMN2KMT2AKDM4EEPHX2
SCHEMBL7168527 0.81 L3MBTL1 (0.69) LMNASMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL7238522 0.80 NLRP3 (0.65) LMNASMN1; SMN2HTTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030083523-A1 Amide derivatives MITSUBISHI CHEMICAL CORPORATION (JP) 2003-05-01 US disclosed
US-6444849-B1 BACTERICIDES MITSUBISHI CHEMICAL CORPORATION (JP) 2002-09-03 US disclosed
EP-0887341-A1 Amide derivatives MITSUBISHI CHEMICAL CORPORATION (JP) 1998-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083523-A1 Amide derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, CBR1 LMNA 1674/4885SMN1; SMN2 4084/4885HTT 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.